Streetbeat News

Price Targets

ROIV

Roivant Sciences (NASDAQ:ROIV) has received positive analyst ratings in the last quarter, with 5 bullish and 2 somewhat bullish ratings out of 7. The average price target is $16.57, representing a significant upside from the current price of $9.99. This target has increased by 5.74% from the previous target of $15.67. Analysts derive their ratings from various sources, including company data and insider information.

Portfolio Pulse from Benzinga Insights

December 12, 2023 | 12:00 pm

NSSC

Needham analyst James Ricchiuti has reaffirmed a Buy rating on NAPCO Security Technologies (NASDAQ:NSSC) and increased the price target from $34 to $36.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 11:49 am

ACLX

Needham analyst Gil Blum has reiterated a Buy rating on Arcellx (NASDAQ: ACLX) and maintained a $65 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 11:47 am

VEL

BTIG analyst Sarah Barcomb has maintained a Buy rating on Velocity Financial (NYSE:VEL) and increased the price target from $14 to $17, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 11:45 am

NKTX

Needham analyst Gil Blum has reiterated a Buy rating on Nkarta (NASDAQ:NKTX) and maintained a $15 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 11:45 am

AXSM

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on Axsome Therapeutics (NASDAQ:AXSM) and maintained a price target of $180.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 11:43 am

TPR

Morgan Stanley analyst Alexandra Steiger has reinstated an Equal-Weight rating on Tapestry (NYSE:TPR) and set a price target of $38.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 11:41 am

MAA

Morgan Stanley analyst Adam Kramer has initiated coverage on Mid-America Apartment Communities, Inc. (NYSE: MAA) with an Equal-Weight rating and set a price target of $128.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 11:39 am

CPT

Morgan Stanley analyst Adam Kramer has initiated coverage on Camden Prop Trust (NYSE:CPT) with an Equal-Weight rating and set a price target of $95.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 11:38 am

ADBE

Citigroup analyst Tyler Radke has maintained a Neutral rating on Adobe (NASDAQ:ADBE) while raising the price target from $610 to $675. This adjustment reflects a more optimistic valuation of Adobe's future performance while not fully committing to a buy recommendation.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 11:32 am